​

Funding Round

Series B - Causaly

Series B - Causaly

Investment Firm

Overview

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

Announced Date

Jul 13, 2023

Closed on Date

Jul 13, 2023

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

ICONIQ Growth

ICONIQ Growth

ICONIQ Growth is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

7

Investor Name
Participant InvestorOlivier Pomel
Participant InvestorVisionaries Club
Participant InvestorMarathon Venture Capital
Participant InvestorIndex Ventures
Participant InvestorPentech Ventures

Round Details and Background

Causaly raised $60000000 on 2023-07-13 in Series B

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 20, 2019
Series A - Causaly
3-4.8M
May 17, 2021
Series A - Causaly
3-17.0M
Oct 24, 2022
Venture Round - Causaly
-10.0M
Jul 13, 2023
Series B - Causaly
7-60.0M

Recent Activity

There is no recent news or activity for this profile.